Ruth Barrow, MD
Obstetrics & Gynecology · New York, NYNPI 1851428379
Payments from drug & device makers
Across 124 payments — averaging $25.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$520
- Mayne Pharma Commercial LLC$486
- Astellas Pharma US Inc$448
- Daiichi Sankyo Inc.$327
- Evofem Biosciences, Inc.$182
- Sumitomo Pharma America, Inc.$176
- plus $987 from 19 others
What the payments were for
- Food & beverage$3,03197%
- Education$943%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 21 | $520 |
| Mayne Pharma Commercial LLC | 16 | $486 |
| Astellas Pharma US Inc | 16 | $448 |
| Daiichi Sankyo Inc. | 10 | $327 |
| Evofem Biosciences, Inc. | 9 | $182 |
| Sumitomo Pharma America, Inc. | 9 | $176 |
| Pfizer | 5 | $87 |
| Myovant Sciences Inc. | 4 | $86 |
| Exact Sciences | 3 | $82 |
| Agile Therapeutics, Inc. | 4 | $80 |
| Biogen | 3 | $75 |
| Amgen | 4 | $72 |
| Coopersurgical, Inc. | 3 | $60 |
| Hologic Sales And Service, LLC | 1 | $58 |
| Pacira Pharmaceuticals Incorporated | 2 | $52 |
| Sanofi Pasteur Inc. | 2 | $50 |
| Heron Therapeutics, Inc. | 1 | $46 |
| Therapeuticsmd, Inc. | 2 | $39 |
| Medtronic | 1 | $38 |
| Novo Nordisk | 2 | $34 |
| Scynexis, Inc. | 1 | $31 |
| Avion Pharmaceuticals | 2 | $30 |
| Dexcom, Inc. | 1 | $27 |
| Bausch Health US, LLC | 1 | $22 |
| Exeltis, USA Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INJECTAFER$124
- NEXTSTELLIS$122
How this compares
$3,125 in reported general payments places this provider in the 85th percentile of 2,673 obstetrics & gynecology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 11 | $320 |
| FyavolvNorethindrone Ac/Eth Estradiol | 13 | $307 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 12 | $205 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 12 | $107 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in New York
- Jin Hee KimNew York$1M
- Carolyn WesthoffNew York$935K
- Mary PolanNew York$862K
- Steven GoldsteinNew York$557K
- Veronica LernerNew York$368K
- Rachana GavaraNew York$290K
- Taraneh ShirazianNew York$287K
- Lisa EngNew York$237K
- Monica DragomanNew York$230K
- Rachel MaschNew York$187K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.